Evidence map›Paper›PMID 27537405›Full record

SynthesisPloS one2016

Evaluation of Immunofluorescence Antibody Test Used for the Diagnosis of Canine Leishmaniasis in the Mediterranean Basin: A Systematic Review and Meta-Analysis.

Amel Adel, Dirk Berkvens, Emmanuel Abatih, Abdelkrim Soukehal, Juana Bianchini, Claude Saegerman

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. First Evidence ofAnimals : an open access journal from MDPI · 2024
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Use of GnRH Agonist in Dogs Affected with Leishmaniosis.Animals : an open access journal from MDPI · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Serological and Molecular Findings ofPathogens (Basel, Switzerland) · 2019
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Amel AdelInstitute of Veterinary Sciences, University Saad Dahlab, Blida, Algeria.
Dirk BerkvensInstitute of Tropical Medicine, Department of Biomedical Sciences, Antwerpen, Belgium.
Emmanuel AbatihInstitute of Tropical Medicine, Department of Biomedical Sciences, Antwerpen, Belgium.
Abdelkrim SoukehalUniversity Hospital of Beni Messous, Algiers, Algeria.
Juana BianchiniResearch Unit of Epidemiology and Risk Analysis applied to veterinary science (UREAR-ULg), Fundamental and Applied Research for Animals & Health (FARAH) Center, Faculty of Veterinary Medicine, University of Liege, Liege, Belgium.
Claude SaegermanResearch Unit of Epidemiology and Risk Analysis applied to veterinary science (UREAR-ULg), Fundamental and Applied Research for Animals & Health (FARAH) Center, Faculty of Veterinary Medicine, University of Liege, Liege, Belgium.
Instituut voor Tropische Geneeskunde · BEUniversity of Liège · BEUniversity of Algiers Benyoucef Benkhedda · DZUniversity of Blida · DZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With an expected sensitivity (Se) of 96% and specificity (Sp) of 98%, the immunofluorescence antibody test (IFAT) is frequently used as a reference test to validate new diagnostic methods and estimate the canine leihmaniasis (CanL) true prevalence in the Mediterranean basin. To review the diagnostic accuracy of IFAT to diagnose CanL in this area with reference to its Se and Sp and elucidate the potential causes of their variations, a systematic review was conducted (31 studies for the 26-year period). Three IFAT validation methods stood out: the classical contingency table method, methods based on statistical models and those based on experimental studies. A variation in the IFAT Se and Sp values and cut-off values was observed. For the classical validation method based on a meta-analysis, the Se of IFAT was estimated in this area as 89.86% and 31.25% in symptomatic and asymptomatic dogs, respectively. The Sp of IFAT was estimated in non-endemic and endemic areas as 98.12% and 96.57%, respectively. IFAT can be considered as a good standard test in non-endemic areas for CanL, but its accuracy declines in endemic areas due to the complexity of the disease. Indeed, the accuracy of IFAT is due to the negative results obtained in non-infected dogs from non-endemic areas and to the positive results obtained in sera of symptomatic dogs living in endemic areas. But IFAT results are not unequivocal when it comes to determining CanL infection on asymptomatic dogs living in endemic areas. Statistical methods might be a solution to overcome the lack of gold standard, to better categorize groups of animals investigated, to assess optimal cut-off values and to allow a better estimate of the true prevalence aiming information on preventive/control measures for CanL.

Indexed as

AnimalsDog DiseasesDogsFluorescent Antibody Technique, DirectLeishmaniasisMediterranean RegionReproducibility of ResultsSensitivity and Specificity

Identifiers

PMID27537405
PMCPMC4990183
OpenAlexW2510736604

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.